Rhea M Shields
Examiner (ID: 2487, Phone: (571)272-3848 , Office: P/2915 )
Most Active Art Unit | 2915 |
Art Unit(s) | 2915 |
Total Applications | 3243 |
Issued Applications | 2995 |
Pending Applications | 31 |
Abandoned Applications | 206 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4463905
[patent_doc_number] => 07935515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Recombinant microalgae cells producing novel oils'
[patent_app_type] => utility
[patent_app_number] => 12/628150
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 62595
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935515.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628150
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628150 | Recombinant microalgae cells producing novel oils | Nov 29, 2009 | Issued |
Array
(
[id] => 7670323
[patent_doc_number] => 20110319592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands'
[patent_app_type] => utility
[patent_app_number] => 13/129009
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13764
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129009
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129009 | Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands | Nov 12, 2009 | Abandoned |
Array
(
[id] => 8187115
[patent_doc_number] => 20120116027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 13/128770
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19691
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20120116027.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128770 | PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS | Nov 12, 2009 | Abandoned |
Array
(
[id] => 7523058
[patent_doc_number] => 08026214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Liquid, aqueous pharmaceutical compositions of factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/617471
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16397
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12617471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617471 | Liquid, aqueous pharmaceutical compositions of factor VII polypeptides | Nov 11, 2009 | Issued |
Array
(
[id] => 6222631
[patent_doc_number] => 20100056472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'GRAIN COMPOSITIONS CONTAINING PRE-BIOTIC ISOMALTO-OLIGOSACCHARIDES AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/616595
[patent_app_country] => US
[patent_app_date] => 2009-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16756
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12616595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/616595 | Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same | Nov 10, 2009 | Issued |
Array
(
[id] => 6222476
[patent_doc_number] => 20100056452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'ANGIOGENESIS-PROMOTING SUBSTRATE'
[patent_app_type] => utility
[patent_app_number] => 12/615549
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3675
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056452.pdf
[firstpage_image] =>[orig_patent_app_number] => 12615549
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/615549 | ANGIOGENESIS-PROMOTING SUBSTRATE | Nov 9, 2009 | Abandoned |
Array
(
[id] => 6280025
[patent_doc_number] => 20100119453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE'
[patent_app_type] => utility
[patent_app_number] => 12/581032
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8269
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581032
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581032 | Methods of enhancing functioning of the large intestine | Oct 15, 2009 | Issued |
Array
(
[id] => 8955664
[patent_doc_number] => 08501436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester'
[patent_app_type] => utility
[patent_app_number] => 12/578709
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6449
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578709 | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester | Oct 13, 2009 | Issued |
Array
(
[id] => 7527036
[patent_doc_number] => 08043627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix'
[patent_app_type] => utility
[patent_app_number] => 12/572884
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4942
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/043/08043627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12572884
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572884 | Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix | Oct 1, 2009 | Issued |
Array
(
[id] => 4618998
[patent_doc_number] => 07998714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Process for accelerated capture of carbon dioxide'
[patent_app_type] => utility
[patent_app_number] => 12/569850
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 29818
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998714.pdf
[firstpage_image] =>[orig_patent_app_number] => 12569850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/569850 | Process for accelerated capture of carbon dioxide | Sep 28, 2009 | Issued |
Array
(
[id] => 8282898
[patent_doc_number] => 08217003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Peptide toxin formulation'
[patent_app_type] => utility
[patent_app_number] => 12/568400
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13567
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12568400
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568400 | Peptide toxin formulation | Sep 27, 2009 | Issued |
Array
(
[id] => 6379255
[patent_doc_number] => 20100081790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Production method of gelatin particles'
[patent_app_type] => utility
[patent_app_number] => 12/585834
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5630
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585834
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585834 | Production method of gelatin particles | Sep 24, 2009 | Issued |
Array
(
[id] => 6596321
[patent_doc_number] => 20100062526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'OPTIMIZED MESSENGER RNA'
[patent_app_type] => utility
[patent_app_number] => 12/558219
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 23973
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12558219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558219 | OPTIMIZED MESSENGER RNA | Sep 10, 2009 | Abandoned |
Array
(
[id] => 6317347
[patent_doc_number] => 20100112654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL'
[patent_app_type] => utility
[patent_app_number] => 12/556550
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 55607
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12556550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/556550 | Microorganisms for the production of 1,4-butanediol | Sep 8, 2009 | Issued |
Array
(
[id] => 8340325
[patent_doc_number] => 08242250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Nucleic acid molecule encoding a cystine knot polypeptide'
[patent_app_type] => utility
[patent_app_number] => 12/548117
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17220
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12548117
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/548117 | Nucleic acid molecule encoding a cystine knot polypeptide | Aug 25, 2009 | Issued |
Array
(
[id] => 6371569
[patent_doc_number] => 20100075379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'METHOD FOR MAKING POLYALKYLENE OXIDE MODIFIED HEMOGLOBIN'
[patent_app_type] => utility
[patent_app_number] => 12/536842
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8097
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075379.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536842 | Method for making polyalkylene oxide modified hemoglobin | Aug 5, 2009 | Issued |
Array
(
[id] => 7586779
[patent_doc_number] => 20110281289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'QUANTIFICATION OF ENZYME ACTIVITY BY MASS SPECTROMETRY USING IMMOBILIZED SUBSTRATES'
[patent_app_type] => utility
[patent_app_number] => 13/003731
[patent_app_country] => US
[patent_app_date] => 2009-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17624
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281289.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003731 | QUANTIFICATION OF ENZYME ACTIVITY BY MASS SPECTROMETRY USING IMMOBILIZED SUBSTRATES | Jul 12, 2009 | Abandoned |
Array
(
[id] => 5484964
[patent_doc_number] => 20090274729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'MEDIA FOR CLOSTRIDIUM BACTERIUM AND PROCESSES FOR OBTAINING A CLOSTRIDIAL TOXIN'
[patent_app_type] => utility
[patent_app_number] => 12/501376
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14466
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12501376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/501376 | Media for clostridium bacterium and processes for obtaining a clostridial toxin | Jul 9, 2009 | Issued |
Array
(
[id] => 7730120
[patent_doc_number] => 08101718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-24
[patent_title] => 'Methods of administering porcine B-domainless fVIII'
[patent_app_type] => utility
[patent_app_number] => 12/496516
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11484
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/101/08101718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496516
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496516 | Methods of administering porcine B-domainless fVIII | Jun 30, 2009 | Issued |
Array
(
[id] => 5474286
[patent_doc_number] => 20090247452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'PHARMACEUTICAL FORMULATIONS FOR REDUCING PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/483673
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9540
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247452.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483673 | Pharmaceutical formulations for reducing pain | Jun 11, 2009 | Issued |